Previous reports demonstrate that the microbiome impacts allergic airway responses, including airway hyperresponsiveness, a characteristic feature of asthma. Here we examined the role of the microbiome in pulmonary responses to a nonallergic asthma trigger, ozone. We depleted the microbiota of conventional mice with either a single antibiotic (ampicillin, metronidazole, neomycin, or vancomycin) or a cocktail of all four antibiotics given via the drinking water. Mice were then exposed to room air or ozone. In air-exposed mice, airway responsiveness did not differ between antibiotic-and control water-treated mice. Ozone caused airway hyperresponsiveness, the magnitude of which was decreased in antibiotic cocktail-treated mice versus water-treated mice. Except for neomycin, single antibiotics had effects similar to those observed with the cocktail. Compared with conventional mice, germ-free mice also had attenuated airway responsiveness after ozone. 16S ribosomal RNA gene sequencing of fecal DNA to characterize the gut microbiome indicated that bacterial genera that were decreased in mice with reduced ozone-induced airway hyperresponsiveness after antibiotic treatment were short-chain fatty acid producers. Serum analysis indicated reduced concentrations of the short-chain fatty acid propionate in cocktail-treated mice but not in neomycin-treated mice. Dietary enrichment with pectin, which increased serum short-chain fatty acids, also augmented ozone-induced airway hyperresponsiveness. Furthermore, propionate supplementation of the drinking water augmented ozone-induced airway hyperresponsiveness in conventional mice. Our data indicate that the microbiome contributes to ozone-induced airway hyperresponsiveness, likely via its ability to produce short-chain fatty acids.
Clinical Relevance
This study demonstrates a role for the gut microbiome in pulmonary responses to ozone, an asthma trigger. The data indicate that the ability of the microbiome to produce shortchain fatty acids likely contributes to this role. A better understanding of the relationship between the microbiome and asthma could lead to new diagnostic biomarkers for asthma and novel therapeutics, including probiotics and prebiotics.
There is increasing evidence that the microbiome plays an important role in asthma (1) (2) (3) . Patients with asthma harbor different microbes in their lungs and sputum compared with healthy humans (3, 4) . In addition, children whose guts are colonized with Helicobacter pylori are 40% less likely to have childhood-onset asthma than children who are not colonized (5) . Prenatal and postnatal uses of antibiotics in humans have been associated with an increased risk of asthma development (6) , and oral ingestion of various strains of Lactobacillus and ingestion of bacterial products have also been shown to impact allergic pulmonary inflammation (7) . In mice, disruption of the microbiota by antibiotic treatment leads to abnormal allergic airway responses, including increased levels of eosinophils, mast cells, IL-5, IL-13, g-IFN, IgE, and mucus-secreting cells (8) . Similarly, germfree (GF) mice have augmented allergic airway responses compared with mice raised in conventional specific-pathogenfree (SPF) facilities (9) . Taken together, these data support the hypothesis that the microbiome shapes allergic airway responses. However, it is unknown how the microbiome impacts pulmonary responses to nonallergic asthma triggers.
The air pollutant ozone (O 3 ) is a major public health concern worldwide. O 3 exposure causes dyspnea, cough, decreased lung function, susceptibility to lung infections, pulmonary inflammation, and increased asthma exacerbations (10) (11) (12) . Indeed, the number of hospital admissions for asthma increases on days after high ambient O 3 concentrations (13) . O 3 causes airway epithelial cell injury, induces production of inflammatory cytokines and chemokines, and causes neutrophil recruitment (14) . Importantly, O 3 also causes airway hyperresponsiveness (AHR) (15) , a canonical feature of asthma.
Our purpose in this study was to examine the hypothesis that the microbiome contributes to O 3 -induced AHR. To do so, we compared O 3 -induced AHR in SPF versus GF mice, and in control mice versus mice treated with either individual antibiotics (ampicillin, metronidazole, neomycin, and vancomycin) or the combination of these antibiotics. O 3 -induced AHR was attenuated in GF mice, in mice treated with the antibiotic cocktail, and in mice treated with all individual antibiotics except neomycin. 16S ribosomal RNA (rRNA) gene sequencing of fecal DNA indicated that bacterial genera that were associated with O 3 -induced AHR were short-chain fatty acid (SCFA) producers. SCFAs are primarily produced by anaerobic gut bacterial fermentation of fiber, and have been implicated in the role of the microbiome in various diseases, including allergic asthma, insulin sensitivity, and colitis (16) (17) (18) (19) . Serum analysis indicated reduced concentrations of the SCFA propionate in mice with reduced O 3 -induced AHR. Furthermore, diets high in fermentable fiber that also resulted in increased serum SCFAs and propionate supplementation of the drinking water both augmented O 3 -induced AHR. Our data suggest that the microbiome is required for O 3 -induced AHR, likely via its ability to produce SCFAs.
Methods

Animals
All protocols were approved by the Harvard Medical Area Standing Committee on Animals. Male C57BL/6 mice were used and were 10 weeks old at the time of exposure. Further details regarding these animals can be found in the data supplement.
Protocol
Four experimental protocols were performed. In the first protocol, mice were given a cocktail of antibiotics (AMNV [ampicillin 1 g/L, metronidazole 1 g/L, neomycin 1 g/L, and vancomycin 0.5 g/L]) by addition to the drinking water for 2 weeks. Sucralose (8 g/L) was added for taste. This type of antibiotic treatment protocol has been reported to result in a marked reduction in the gut bacteria load as assessed DNA concentration in fecal pellets (20) . Control mice were given regular drinking water with sucralose. Additional mice were treated with each antibiotic given individually for 2 weeks before O 3 exposure and evaluation. After 2 weeks of treatment, the mice were exposed to room air or to O 3 (2 ppm for 3 h). The mice were anesthetized for measurements of pulmonary mechanics and airway responsiveness to inhaled aerosolized methacholine (1-100 mg/ml) 24 hours after exposure. After these measurements, the mice were killed, blood was collected for the preparation of serum, and BAL was performed. Fecal samples were collected from each mouse 1 day before exposure. In the second protocol, GF mice were administered the same cocktail of antibiotics or control water for 2 weeks inside isolator cages. They were then taken out of the isolators, immediately exposed to O 3 , and evaluated 24 hours later. GF mice were compared with SPF mice that had also been exposed to O 3. In the third protocol, mice were placed on diets in which 30% of the calories derived from fiber, either in the form of pectin or in the form of cellulose. The diets were obtained from Research Diets Inc. After 3 days the mice were exposed and evaluated as described above. In the fourth protocol, mice were given sodium propionate (200 mM) in the drinking water for 3 days before O 3 exposure. Control mice were given saline (50 mM) in the drinking water, as described previously (16) . In all protocols, treatment (antibiotics, propionate, or diet) was continued in the period between exposure and evaluation.
The methods used for O 3 exposure, measurements of airway responsiveness, BAL, 16S rRNA gene sequencing and analysis, and measurement of SCFAs are detailed in the data supplement.
Statistical Analysis
Except for microbial community analysis (see the data supplement), the significance of differences between groups was assessed using ANOVA (for SCFAs) or factorial ANOVA combined with Fisher's least significant difference post hoc analysis (Statistica Software) using treatment and exposure as main effects. Student's t test was used for the GF mice and the exogenous propionate experiment. A P value , 0.05 (two-tailed) was considered significant. All values are expressed as mean 6 SEM.
Results
Treatment with an Antibiotic Cocktail Reduces Responses to O 3
To deplete the microbiome, mice were administered an antimicrobial cocktail (AMNV) by addition to the drinking water for 2 weeks. Treatment with the AMNV cocktail did not affect body weight (26.8 6 0.7 g vs. 27.8 6 0.6 g). After exposure to room air, airway responsiveness to methacholine did not differ between mice given regular drinking water and those treated with the AMNV cocktail ( Figure 1A ), except at the PBS dose (see Figure E1 for an expanded scale of the responses at the lowest doses of methacholine for this and other figures displaying airway responsiveness data). In O 3 -exposed water-treated mice, O 3 exposure resulted in increased airway responsiveness, as assessed by changes in respiratory system resistance (R RS ) ( Figure 1A ) or respiratory system elastance (E RS ) ( Figure E2 ). O 3 also increased BAL neutrophils and macrophages and BAL protein, a marker of damage to the alveolar/capillary barrier (21) ( Figures  1A-1D ), consistent with previous reports (21) (22) (23) . Compared with water-treated mice, O 3 -exposed AMNV-treated mice had significantly reduced airway responsiveness when assessed using R RS ( Figure 1A ), but not E RS ( Figure E2 ), suggesting that the effect of antibiotics was not mediated at the level of changes in airway closure. AMNV treatment also resulted in lower BAL neutrophils ( Figure 1B ), but did not impact O 3 -induced increases in BAL macrophages or protein ( Figures 1C and 1D ). Together, these findings indicated that the microbiome contributes to the development of AHR and neutrophilic inflammation in the lung after O 3 exposure, without affecting lung barrier injury.
The cytokines IL-17A and osteopontin have each been reported to play a role in O 3 -induced AHR in mice (22) (23) (24) . IL-33-induced activation of innate lymphoid cells type 2 has also been reported to contribute (25, 26) . Compared with air, O 3 caused a significant increase in BAL concentrations of IL-17A, osteopontin, IL-33, and IL-5, a marker of innate lymphoid cell type 2 activation ( Figures E3A-E3D ). However, concentrations of these cytokines did not differ between water-treated and antibiotic-treated mice.
We recently reported that gastrinreleasing peptide (GRP) also contributes to O 3 -induced AHR (24) . Named for its ability to promote gastrin release in the stomach, GRP also affects the release of other gastrointestinal hormones (27) , and has effects on gastrointestinal motility (28) . Importantly, GRP also causes airway smooth muscle contraction (29) . Consequently, we also measured GRP in BAL fluid of mice treated with antibiotics or control water ( Figure E3E ). BAL levels of GRP were higher in O 3 -exposed mice than in air-exposed mice, as previously described (24), but there was no impact of antibiotic treatment on BAL GRP.
Several other BAL cytokines and chemokines, including granulocyte colony stimulating factor (G-CSF), eotaxin, IL-6, IP-10, leukemia inhibitory factor (LIF), monocyte chemoattractant protein 1 (MCP-1), keratinocyte chemoattractant (KC), macrophage inhibitory protein 2 (MIP-2), and macrophage inhibitory factor 1 a (MIP1a symbol) were elevated in O 3 -versus airexposed mice, but none were reduced by antibiotic treatment ( Figure E4 ). O 3 exposure also caused a small but significant increase in BAL LTB 4 with O 3 exposure ( Figure 1E ). Importantly, there was a significant reduction in BAL LTB 4 in mice treated with antibiotics ( Figure 1E ).
GF Mice Have Attenuated Responses to O 3
To confirm that it was indeed microbial perturbation and not an off-target effect of the antibiotic treatment that dampened responses to O 3 ( Figures 1A and 1B) , we next compared the responses of GF and SPF mice exposed to O 3 . Only O 3 -exposed mice were used in experiments on GF mice because antibiotic treatment had no effect in air-exposed mice ( Figure 1A ). The body weights of SPF and GF mice were not different (data not shown). Compared with SPF mice, GF mice had reduced airway responsiveness after O 3 exposure ( Figure 2A ). BAL neutrophils and BAL LTB 4 , but not BAL protein, were also Results are mean 6 SE of data from n = 6-8 per group. *P , 0.05 compared with air-exposed mice given the same treatment; # P , 0.05 compared with mice with control drinking water with the same exposure. R RS = respiratory system resistance.
significantly reduced in O 3 -exposed GF versus SPF mice (Figures 2B-2D ). To further evaluate the possibility of nonspecific effects from the AMNV cocktail, we compared GF mice treated with drinking water with other GF mice that were given the AMNV antibiotic cocktail for 2 weeks before O 3 exposure. Airway responsiveness and BAL neutrophils did not differ between water-treated and antibiotic-treated GF mice exposed to O 3 ( Figures 2E and 2F) , nor was there any difference in body weight (25.5 6 0.6 g vs. 26.8 6 0.7 g). Together, these findings indicate that a decrease in the microbial burden, whether by antibiotic treatment or by GF conditions, results in an attenuation of the response to O 3 in C57BL/6 mice.
Ampicillin, Metronidazole, and Vancomycin, but Not Neomycin, Attenuate O 3 -induced AHR As described above, after O 3 exposure, AMNV-treated SPF mice had reduced airway responsiveness compared with water-treated mice. To narrow down possible microbial taxa involved in modulating airway responsiveness, we measured airway responsiveness in SPF mice treated for 2 weeks either with the AMNV cocktail or with each antibiotic in the cocktail given separately. None of the antibiotics alone or in combination had any effect on the body weight (data not shown) or airway responsiveness of air-exposed mice ( Figure 3A, left panel) . Compared with water treatment, AMNV treatment reduced O 3 -induced AHR ( Figure 3A , right panel), as described above (Figure 1) . Treatment with ampicillin alone, metronidazole alone, or vancomycin alone also resulted in reduced O 3 -induced AHR, whereas mice treated with neomycin alone responded similarly to the water-treated control group ( Figure 3A, right panel) . Similar results were obtained when we computed the ED3 R RS , the dose of methacholine required to cause a 3 cm H 2 O/ml/s change in R RS ( Figure 3B ). These findings eliminate microbial clades that are affected by neomycin as candidate modulators of nonallergic AHR after O 3 exposure.
Bacterial Genera Depleted in Mice with Attenuated O 3 -induced AHR
Others have reported that oral treatment with vancomycin alone does not alter the lung microbiome even though it does affect the gut microbiome (30), likely because vancomycin does not cross the gut epithelium after oral administration (31). Because vancomycin alone was able to attenuate O 3 -induced AHR (Figure 3) , we focused our attention on the gut microbiome. To determine the effect of antimicrobials on the murine gut microbiome, we conducted microbial community 16S rRNA gene amplicon surveys from mouse stool collected with or without antimicrobial treatment (see supplemental METHODS). Statistical association testing of taxonomic profiles and treatment variables demonstrated that both the cocktail and individual antibiotic treatments resulted in significant perturbations in gut microbial ecology ( Figure E5 ). Consistent with other reports (32), several members of the Firmicutes, Bacteroidetes, Actinobacteria, Deferribacteres, and Tenericutes phyla were depleted by the antibiotic treatments, with concurrent enrichment for g-Proteobacteria clades ( Figure E5B) . The phylum-level relative abundances of mice given water and neomycin were quite similar ( Figure E5B ), but significant effects of the neomycin treatment were observed at the genera level ( Figure E6 ), including Anaeroplasma spp and Ruminococcus gnavus, which indicated the overall antibiotic efficacy of the neomycin dose administered. Because our data showed that all individual antibiotic treatments except for neomycin attenuated O 3 -induced AHR (Figure 3 ), we investigated taxa that were significantly affected in the AMNV, ampicillinalone, metronidazole-alone, and vancomycinalone treatment groups, but not in the neomycin-alone treatment group. Relative to water-treated mice, Ruminococcus and Coprococcus genera of the Clostridiales order were reduced in AMNV-, ampicillin-, metronidazole-, and vancomycin-treated mice, but not in neomycin-treated mice (Figure 4) , suggesting that functions of these two genera may be involved in the development of O 3 -induced AHR.
Role of SCFAs
Ruminococcus and Coprococcus genera are notable fermenters of nondigestible carbohydrates, a process that yields SCFA end products, primarily acetate, propionate, and butyrate (33) . SCFAs have previously been implicated in allergen-induced AHR (16) . Hence, we compared serum SCFAs in water-, AMNV-, and neomycin-treated mice. As described above, AMNV treatment reduced O 3 -induced AHR, whereas neomycin treatment did not. Consistent with these results, serum propionate was significantly reduced in AMNV-treated mice (16.6 6 4.3 mM; P , 0.01), but not neomycin-treated mice (43.8 6 1.8 mM), compared with mice treated with control drinking water (39.6 6 5.3 mM) and exposed to air. A similar trend was observed for serum acetate, but not butyrate (data not shown), consistent with reports of others indicating that butyrate produced by gut microbiota is largely cleared before reaching the systemic circulation by intestinal epithelial cells that use it for energy production (34). Other investigators have reported roles for SCFAs in microbiome-dependent effects on allergic airways disease, insulin sensitivity, and colitis (16) (17) (18) (19) . To evaluate the role of microbiota-derived SCFAs in pulmonary responses to O 3 , mice were placed on diets containing pectin (30% by weight). Pectin is a plant fiber that is readily fermented by gut bacteria, yielding SCFAs (16, 35) . Control mice were placed on diets that were compositionally identical except that the plant fiber cellulose, which is not readily fermented by bacteria, was substituted for pectin. Indeed, compared with cellulose treatment, pectin treatment resulted in an approximately 75% increase in total serum SCFAs ( Figure 5A ), consistent with results of others (16) . Body weight did not differ between cellulose-and pectin-treated mice (data not shown). There was no effect of diet on airway responsiveness in airexposed mice ( Figure 5B ), but O 3 caused a greater increase in airway responsiveness in pectin-treated mice than in cellulosetreated mice. In contrast, there was no significant difference in BAL neutrophils in pectin-versus cellulose-treated mice ( Figure 5C ). To determine whether exogenous administration of SCFAs has the capacity to impact responses to O 3 , we administered exogenous propionate to SPF mice for 3 days via their drinking water and then exposed them to O 3 . We chose to administer propionate because others have shown that it alters allergen-induced responses in the airways (16) . Propionate treatment did not affect body weight (data not shown). Airway responsiveness was not affected by propionate treatment in airexposed mice, but was significantly greater in propionate-treated versus saline-treated (control) mice exposed to O 3 ( Figure 6A ). In contrast, BAL neutrophils were not affected by propionate treatment ( Figure  6B ), similar to results obtained with pectin treatment ( Figure 5C ). Together, our results suggest that microbiota-derived SCFAs are involved in the development of O 3 -induced AHR in mice.
Discussion
Our data indicate that both GF mice and mice treated with certain types of antibiotics have reduced O 3 -induced AHR and inflammation. These data indicate that microbiota play a significant role in pulmonary responses to acute O 3 exposure. Importantly, only the antibiotics that caused a significant reduction in two SCFAproducing genera were effective in reducing responses to O 3 . Taken in conjunction with our observations that 1) antibiotic treatments that attenuated O 3 -induced AHR also attenuated serum SCFA, 2) diets that increased serum SCFAs also increased O 3 -induced AHR, and 3) exogenous administration of the SCFA propionate augmented O 3 -induced AHR, our data suggest that the role of microbiota is mediated through their ability to produce SCFAs.
It is possible that the ability of antibiotics to attenuate responses to O 3 was due to the antibiotics affecting bacteria in the lung rather than the gut. Such an explanation could account for the lack of efficacy of the neomycin treatment on O 3 -induced AHR, as after oral administration, both ampicillin and metronidazole are able to cross the gut epithelium, circulate systemically, and hence impact lung microbiota, whereas neomycin is not able to do so (31) . However, vancomycin does not cross the gut epithelium after oral administration either (31) , and others have reported no effect of oral vancomycin on lung bacterial community structure in mice even though vancomycin does substantially affect the gut microbiome (36), consistent with our observations. Nevertheless, vancomycin was as effective as ampicillin or metronidazole in reducing O 3 -induced AHR. Instead, the lack of a significant effect of neomycin versus the other antibiotics likely stems from differences in the gut bacteria targeted by these antibiotics.
Of the bacterial taxa affected by antibiotics, only two were significantly reduced by each of the antibiotic treatments that reduced O 3 -induced AHR (AMNV, ampicillin alone, metronidazole alone, and vancomycin alone) but not by treatment with neomycin alone. Bacteria in these two taxa are well-known plant degraders, fermenting complex carbohydrates into SCFAs such as acetate, propionate, and butyrate, including in human intestines (33, 37) . Indeed, our data suggest that microbiota-derived SCFAs may contribute to the observed role of the microbiome in responses to O 3 , as both mice treated with a diet that promotes SCFA production by gut bacteria and mice treated with exogenous propionate had augmented AHR after O 3 exposure. Whereas SCFAs augmented O 3 -induced AHR, others have reported that increased circulating levels of SCFAs (secondary to a high-pectin diet) attenuate AHR induced by allergen (16, 18) . The reason for these disparate effects of SCFAs likely lies in the different factors driving O 3 -induced versus allergen-induced AHR. Trompette and colleagues (16) showed that the ability of SCFAs to attenuate allergeninduced AHR was the result of reduced dendritic cell hematopoiesis leading to a diminished T-helper cell type 2 cell response. In contrast, dendritic cells do not appear to be involved in mediating the effects of O 3 (38) . Others have reported that the role of SCFAs in disease states differs depending on whether the innate or adaptive immune system is involved (39) . For example, in models where the adaptive immune system is important, such as allergic airways disease (16) and experimental autoimmune encephalomyelitis (39) , SCFA treatment is found to be beneficial. On the other hand, in models in which only the innate immune system is involved, such as the initial stages of antigen-induced arthritis and Parkinson's disease, SCFAs exacerbate inflammation and symptom severity (39, 40) . Hence, the pulmonary response to acute O 3 exposure, which involves activation of the innate immune system (25), may be similarly negatively affected by SCFAs.
We do not know exactly how SCFAs affect O 3 -induced AHR. However, SCFAs can affect expression of certain cytokines, including some that have previously been implicated in O 3 -induced AHR and inflammation (30, 41) . Nevertheless, when we assessed the BAL concentrations of IL-17A, osteopontin, IL-33, and GRP, each of which has been reported to play a role in O 3 -induced AHR in mice, cytokine levels did not differ between water-treated and antibiotic-treated mice, nor did we observe any change in BAL IL-17A, IL-33, or GRP in O 3 -exposed mice after propionate treatment (data not shown) even though AHR was affected. It is also possible that SCFAs could promote AHR by acting directly on airway smooth muscle cells, which express receptors for SCFAs (42) . However, we found no change in serum propionate after administration of propionate via the drinking water (data not shown), indicating that the propionate we administered did not reach the lungs even though it was able to augment O 3 -induced AHR. These data are consistent with reports of others indicating that propionate administered via the gut is largely cleared by enterocytes and hepatocytes before reaching the systemic circulation (34, 43) . These data suggest that intestinal epithelial cells and/or the liver are the likely sites of action of SCFAs in mediating the observed effects of propionate on the lung. Indeed, SCFAs cause the release of intestinal hormones such as GLP1 and PYY (44) , and activate intestinal vagal afferents (45) , either of which could affect the lungs.
Antibiotics and GF conditions attenuated not only O 3 -induced AHR but also O 3 -induced increases in BAL neutrophils. However, the mechanistic bases for the effects of the microbiome on AHR and neutrophils appear to differ. Whereas microbiota-dependent changes in SCFAs appear to account for the effects of the microbiome on O 3 -induced AHR, neither exogenous administration of SCFAs nor SCFA-producing diets had any significant effect on O 3 -induced changes in BAL neutrophils. Instead, microbiomedependent effects on the production of LTB 4 , a chemotactic factor that is known to contribute to O 3 -induced neutrophil recruitment (46) , may account for the effects of antibiotics and GF conditions on O 3 -induced neutrophil recruitment. BAL LTB 4 was significantly reduced in both antibiotic-treated and GF mice. Others have reported that prebiotics that are capable of altering the microbiome also attenuate colonic LTB 4 production in a rat colitis model (47) . Although it is conceivable that microbiome-dependent effects on LTB 4 also contributed to O 3 -induced AHR (48), we were unable to detect any effect of propionate administration on BAL LTB 4 (data not shown) despite the marked effects of propionate on O 3 -induced AHR.
One technical issue requires consideration. We performed experiments in C57BL/6 mice from two different vendors: Taconic Farms and The Jackson Laboratory. Others have reported differences in the taxonomic composition of the gut microbiome in mice from these vendors (49) , and our data (not shown) confirm such vendor differences. Given the observed role for the microbiome in pulmonary responses to O 3 , it may be surprising that mice from these two vendors had similar responses to O 3 (compare water-treated mice in Figure 1 and SPF mice in Figure 2 ). In this respect, it is important to note that many different bacterial taxa can fill the same functional niche within the gut microbial community structure. Indeed, even though mice from the two vendors had different microbiomes, they had the same serum SCFA levels (data not shown), consistent with their similar responses to O 3 .
In summary, our study indicates a role for the gut microbiome in pulmonary responses to acute O 3 exposure. Our findings also suggest that the ability of the microbiome to produce SCFAs likely contributes to this role. A better understanding of the relationship between the microbiome and asthma could lead to new diagnostic biomarkers for asthma and novel therapeutics, including probiotics and prebiotics. n Author disclosures are available with the text of this article at www.atsjournals.org.
